Recent Comments
    Categories

    Archive for the ‘RADIATION’ Category

    THE BIKINI ATTOL EXPERIMENT WITH RADIATION ON ITS PEOPLE

    Friday, September 9th, 2011

    NUCLEAR RADIATION EXPERIMENT – PROJECT 4.1 MARSHALL ISLANDS

    Project 4.1 was the designation for a medical study conducted by the United States of those residents of the Marshall Islands exposed to radioactive fallout from the March 1, 1954 Castle Bravo nuclear test at Bikini Atoll, which had an unexpectedly large yield. For the first 10 years or so after the test, the effects were ambiguous and statistically difficult to correlate in radiation exposure: Miscarriages and stillbirths among exposed Rongelap women doubled in the first five years after the accident, but then returned to normal; some developmental difficulties and impaired growth appeared in children, but in no clear-cut pattern. In the decades that followed, though, the effects were undeniable. Children began to suffer disproportionately from thyroid cancer (due to exposure to radioiodines), and almost a third of those exposed developed neoplasms by 1974.

    As a Department of Energy Committee writing on the human radiation experiments wrote, “It appears to have been almost immediately apparent to the AEC and the Joint Task Force running the Castle series that research on radiation effects could be done in conjunction with the medical treatment of the exposed populations.” The Department of Energy report also concluded that “The dual purpose of what is now a DOE medical program has led to a view by the Marshallese that they were being used as ‘guinea pigs’ in a possible ‘radiation experiment.

    Sourced & published by Henry Sapiecha

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    RADIATION SICKNESS CURE NOW POSSIBLE????READ THIS…

    Thursday, April 14th, 2011

    Possible cure for radiation sickness discovered?

    By Darren Quick

    23:38 July 21, 2009

    No need to worry, it's just a nuclear blast

    No need to worry, it’s just a nuclear blast

    According to a report in the Israeli newspaper, Yediot Ahronoth, US and Israeli researchers have developed a drug that offers protection from the damaging effects of radiation sickness. The medication could not only provide effective protection in the event of a nuclear or “dirty bomb” attack, but it could also enable cancer patients to be treated with more powerful doses of radiation.

    Experiments carried out by Professor Andrei Gudkov, Chief Scientific Officer at Cleveland BioLabs, and his team exposed more than 650 monkeys split into two groups to a radiation dosage equal to the highest dosage sustained by humans as a result of the Chernobyl disaster. Of the group that didn’t receive the cure 70% died, with the survivors suffering from the obvious effects of radiation sickness. However, almost all the monkeys in the group given the medication survived, with most of them exhibiting no side effects.

    The tests also showed that injecting the medication between 24 hours before exposure to 72 hours after exposure produced similar results, although Prof. Gudkov emphasized that the drug doesn’t provide 100% protection against radioactive damage. Another test, which involved giving the drug to humans without exposing them to radiation, showed no signs of side effects and indicated the drug is safe for human use.

    The medication is the end result of an idea Prof. Gudkov had in 2003 to use protein produced in bacteria found in the intestine to protect cells from radiation. Five years and much hard work later has produced a medication that works by suppressing the “suicide mechanism” of cells hit by radiation, while at the same time enabling them to recover from the radiation-induced damage that triggered the suicide mechanism in the first place. The medication itself is not a vaccine, but a preventative drug that is administered as one or a series of injections.

    Thanks to a shortened test track approved for bio-defense drugs Prof. Gudkov’s company expects to complete a set of expanded safety tests by mid-2010, with the medication expected to be approved for use by the FDA within a year or two, provided experiments continue at the current rate.

    Israeli news site, YNet News, points to the strategic military advantage such a breakthrough would deliver as well as the medical importance of the medication, which could allow cancer patients to be exposed to greater doses of radiation offering a more powerful weapon in the fight against the disease. The medication could also provide some comfort for those situated close to nuclear power stations.

    Source: YNet News, Cleveland BioLabs.

    Sourced & published by Henry Sapiecha

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS
    Bookmarks
    Sponsors